Bisphosphonates and breast carcinoma
The skeleton is a common site of breast carcinoma metastasis; 75% of patients with breast carcinoma demonstrate bone metastases at autopsy. The lytic destruction of bone in these patients is due to excessive osteoclastic activity. By reducing osteoclastic activity, bisphosphonates inhibit bone resor...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Revisão |
| Kieli: | englanti |
| Julkaistu: |
1997
|
| Linkit: | https://doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1668::aid-cncr17>3.3.co;2-5 https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819971015%2980%3A8%20%3C1668%3A%3AAID-CNCR17%3E3.0.CO%3B2-Y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|